Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04814914 · ClinicalTrials.gov registry record
An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120
A clinical trial, sponsored by Kaleido Biosciences.
- Completed
- Registry status
- 333
- Enrollment target
NCT04814914: Completed study, sponsored by Kaleido Biosciences.
NCT04814914 is a clinical trial that has completed, run by Kaleido Biosciences. The registered enrollment target is 333 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04814914 has completed, sponsored by Kaleido Biosciences.
- COMPLETED
- Registry status
- 333 participants
- Enrollment target
Study Summary
This observational clinical study aims to evaluate the presence of symptoms of COVID-19 infection in patients who participated in K031-120 or K032-120 ("long hauler").
Interventions
- OTHER Self Supportive Care (SSC) Alone
- OTHER KB109 + Self Supportive Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2021-03-25 |
| Est. Completion | 2021-05-28 |
What the finished NCT04814914 record still lists
NCT04814914 is an observational study that tracks outcomes without assigning an intervention. The registered 333 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Self Supportive Care (SSC) Alone is the first listed.
NCT04814914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04814914 about?
NCT04814914 is a clinical study titled "An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120". This observational clinical study aims to evaluate the presence of symptoms of COVID-19 infection in patients who participated in K031-120 or K032-120 ("long hauler").
What is the current status of trial NCT04814914?
This trial is currently completed. The enrollment target is 333 participants. The study started on 2021-03-25. Estimated completion is 2021-05-28.
What interventions are being tested in trial NCT04814914?
The interventions under investigation include: Self Supportive Care (SSC) Alone (OTHER), KB109 + Self Supportive Care (OTHER).
Who is sponsoring clinical trial NCT04814914?
This trial is sponsored by Kaleido Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07395687 · 333 participants · Phase 2
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI